PI Focus: Velocity PI Leads Breakthrough Efforts to Combat Obesity, Diabetes

The Velocity Clinical Research team in Los Angeles, CA, is tackling two of the biggest health threats to Americans today: obesity and diabetes. Better still, they’re making tremendous progress against these conditions that exact a terrible toll on quality of life and longevity. Consider these sobering statistics from the Centers for Disease Control and Protection … Read more

Velocity PAC Insights: Communicating With Participants, Cutting No-Shows, and Improving Informed Consent

Velocity Clinical Research maintains a Participant Advisory Committee (PAC) — a diverse mix of current and past trial participants across the U.S. The PAC’s job? Providing participant input to fine-tune the clinical research process. In this piece, we dig into highlights from PAC’s recent meetings in March, April, and May 2023. We’ll cover three key … Read more

PI Focus: Luis De La Cruz, MD on Sleep Apnea

Luis De La Cruz, MD

In this ongoing series, Velocity puts the spotlight on innovative Principal Investigators (PIs) whose work is changing the medical landscape at the intersection of research and patient care.  Velocity Team Contributes to Potential Breakthrough Sleep Apnea Treatment Enjoying a good night’s sleep is vitally important both mentally and physically. Unfortunately, for many it’s a struggle … Read more

Four Takeaways From Velocity’s Clinical Trial Participant Advisory Committee

To gain deeper insight into the perspectives of clinical trial participants, Velocity has built the Participant Advisory Committee (PAC). The PAC comprises diverse current and past clinical trial participants from across the country. The Velocity PAC convenes regularly to discuss issues and share ideas that could improve the clinical research process now and for future … Read more

Case Study: Doubling the Average Participation Rate of Diverse Populations in Cognivue’s FOCUS Study

Neuroscience company Cognivue enrolled more than double the national average participation rate of diverse populations in its Further the Objective and Clinical Understanding of Cognivue Study (FOCUS) study. Velocity supported the study by enrolling the entirety of the study’s more than 1,500 subjects across 14 sites and 11 states. While typical studies of this size … Read more

8 Insights From 9,000+ Real Clinical Trial Participant Surveys

Clinical trials — especially high-volume trials — are primarily designed to collect quantitative data. Collecting and reviewing qualitative data and experiential feedback from trial participants is rarely prioritized. Before being acquired by Velocity Clinical Research, Meridian Clinical Research built an in-house surveying system to elevate the participant’s voice. The system, which is largely automated, collects … Read more

Velocity Publishes 2022 U.S. Patient Survey

In 2022 Velocity undertook its first national survey in the U.S. of patients who have previously taken part in clinical research, receiving 1,129 responses. We wanted to gauge views and attitudes on taking part in clinical research, including thoughts regarding decentralization and the use of technology. The results led us to three key insights and … Read more